A Reversible Carnitine Palmitoyltransferase (CPT1) Inhibitor Offsets Chronic Lymphocytic Leukemia Cell Proliferation

Authors

Elena Gugiatti
Claudya Tenca
Silvia Ravera
Marina Fabbi
Fabio Ghiotto
Zbigniew Darzynkiewicz, New York Medical CollegeFollow
Silvia Bruno

DOI

10.3324/haematol.2017.175414

Journal Title

Haematologica

First Page

e531

Last Page

e536

Document Type

Article

Publication Date

11-1-2018

Department

Pathology, Microbiology and Immunology

Keywords

Apoptosis, Cell Therapy and Immunotherapy, Chronic Lymphocytic Leukemia

Disciplines

Medicine and Health Sciences

Comments

Please see the work itself for the complete list of authors.

Recommended Citation

Gugiatti, E., Tenca, C., Ravera, S., Fabbi, M., Ghiotto, F., Darzynkiewicz, Z., & Bruno, S. (2018). A Reversible Carnitine Palmitoyltransferase (CPT1) Inhibitor Offsets Chronic Lymphocytic Leukemia Cell Proliferation. Haematologica, 103, e531-e536. https://doi.org/10.3324/haematol.2017.175414

Publisher's Statement

Originally published in Haematologica, 103, e531-e536. The original material can be found here.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License